Google Health Manager Discusses User Feedback


Loading...

By Neil Versel, contributing editor

November 4, 2008 | Google Health product manager Roni Zeiger remains highly optimistic about the fledgling but high-profile personal health record (PHR) service and data-aggregation platform, but is trying to assuage concerns about consumer privacy and tamp down expectations that the Internet search leader might be able to cure all that ails health care.

“A PHR and platform is necessary but not sufficient,” Zeiger says, echoing the words of national health-IT coordinator Robert Kolodner. (See “Kolodner et al Remain Optimistic for Health 2.0.”) Zeiger spoke to Digital HealthCare & Productivity shortly after appearing on stage with Kolodner and others at a health 2.0 conference in San Francisco. According to Zeiger, there have to be regular and secure data feeds from multiple sources, including physician and hospital electronic health records (EHRs), insurance companies, laboratories, and pharmacies.

Zeiger says that feedback from test users, largely based on a three-month trial with the Cleveland Clinic that ended in August, has been “surprising that it’s consistently supportive.” However, the chief complaint, according to Zeiger, is that users say, “I want to be able to get my data.” He also says consumers have consistently given him a single message: “We want more.”

Anecdotally, patients have regularly been asking doctors for electronic access to personal health information, something that runs counter to the deeply ingrained culture in medicine.

There also remains skepticism about a company like Google having access to such sensitive information. Zeiger says Google Health doesn’t have any plans to put ads on its pages, reiterating the promise made by Google chief executive Eric Schmidt at the 2008 Healthcare Information and Management Systems Society (HIMSS) conference. (See “Google CEO Discusses Google Health.”)

Zeiger says Google Health is being built on two fundamentals: transparency and choice. “We promise that we won’t sell their data, ever,” he says. This runs counter to Google’s corporate strategy of monetizing Internet search results, but Schmidt said Feb. 28 that he expects Google Health to drive users to other, revenue-producing Google services, including the main search engine.

“We won’t share their data unless they tell us it’s OK,” Zeiger adds. He notes that the company has published privacy and security guidelines that Google Health partners must follow. The focus is squarely on consumer control of data, based on opt-in consent.

Google Health also touts a recent partnership with PDX Inc. (Fort Worth, Texas), a company that aggregates data for about 65 pharmacy chains so they can share prescription information in real time. PDX provides patients with medication records through its pharmacy customers and its rx.com Web portal. The company is making prescription data available for import into Google Health, starting with customers of the New York City-based Duane Reade pharmacy chain.

“Fifty million-plus people will be able to access their medication histories in ways that weren’t possible before,” Zeiger says. That is a while off, however. Right now, Google Health’s role is “helping to build the pipes” for interoperable data exchange.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Cmed paper
Next-gen Cloud-based eClinical
Sponsored by Cmed Technology

New technologies are available to leverage Cloud Computing in  managing clinical trial data. This paper discusses a next generation eClinical
platform that:

  • Speeds trial set up
  • Accommodates changes with zero downtime
  • Integrates effectively with other clinical trial technology systems

It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s  particular needs.



Life Science Webcasts & Podcasts

Medidata Solutions

Evaluating a Risk-based Approach to Good Clinical Practice 

medidata5_podcastThe verification of source documents by study monitors at investigational sites is considered a good clinical practice by regulatory authorities overseeing clinical research, and is extremely important to ensuring data quality in clinical trials. Today’s challenging environment is prompting study teams to explore the use of risk-based approaches to monitoring that do not compromise data quality, but allow limited resources to be directed more effectively to where they’re most needed and to the most critical review activities.

In this podcast, industry experts and executives from Medidata will address questions such as:

  • Why are regulatory agencies and industry open to evaluating the new approaches in site monitoring and source document verification (SDV), and what attitudes and reactions towards less than 100% SDV?
  • What factors do research sponsors need to consider in adopting risk-based site monitoring?


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.